Last reviewed: June 9, 2026 Last updated: June 9, 2026 Written by: Jay Hastings, CEO of PlexusDx Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations
Cavazzana-Calvo, M
Their personalized approach focuses on supporting overall wellness, vitality, and nutritional balance through individualized care
This MTX concentration/ treatment time has been shown to cause maximum differential expression of genes in a previous study (Loizeau et al
Other authorsSee publication Progressive brain atrophy in multiple system atrophy: A longitudinal, multi-center magnetic resonance imaging study Movement Disorders See publication This paper determined rates of brain atrophy progression on MRI in patients with multiple system atrophy (MSA) and identified that cerebellar, pontine, and putaminal volumes were the most sensitive to change in mid-stage disease
The dose is escalated over approximately 16 weeks following a protocol similar to Wegovy's escalation schedule